Dr. Boto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 Main St
Bridgeport, CT 06606Phone+1 475-210-5032Fax+1 475-210-5034
Education & Training
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2012 - 2016
Johns Hopkins University School of MedicineClass of 2012
Certifications & Licensure
MD State Medical License 2023 - 2026
VA State Medical License 2023 - 2026
CT State Medical License 2016 - 2025
NJ State Medical License 2023 - 2025
NY State Medical License 2018 - 2025
DC State Medical License 2023 - 2024
PA State Medical License 2014 - 2016- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- 538 citationsFibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3Jun Wang, Miguel F. Sanmamed, Ila Datar, Tina Tianjiao Su, Lan Ji
Cell. 2019-01-10 - 413 citationsSiglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.Jun Wang, Jingwei Sun, Linda N. Liu, Dallas B. Flies, Xinxin Nie
Nature Medicine. 2019-03-04 - 64 citationsRegulation of the NaV1.5 cytoplasmic domain by calmodulinSandra B. Gabelli, Agedi N. Boto, Victoria Halperin Kuhns, Mario A. Bianchet, Federica Farinelli
Nature Communications. 2014-11-05
Journal Articles
- Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer ImmunotherapyDavid L Rimm, Agedi N Boto, Roy S Herbst, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
